Micronit’s main tasks within the consortium are the assistance in manufacturable design and product development of microfluidic devices and back-end processing. This includes R2R-enabled cutting and singulation as well as interfacing, integration, bonding and assembly of microfluidic components.
Micronit specializes in micro- and nanotechnologies. The company produces lab-on-a-chip products used worldwide for DNA analysis and medical testing.
Micronit provides solutions for engineering and manufacturing of microfluidic devices for health and life sciences applications. The company has expertise in a wide variety of materials, including glass, silicon, polymer, and hybrids. It specializes in cleanroom microfabrication and high-tech quality manufacturing. In the NextGenMicrofluidics project, Micronit focuses on the integration and processing of foils and processes such as singulation, cutting, interfacing, bonding, assembly, and quality control. Micronit is also taking an active part in supporting the design and development of R2R-enabled demonstrators and new products within the biomedical and life sciences research fields.